British Biotech plc / Vernalis Group plc

OFT closed case: Anticipated acquisition by British Biotech plc of Vernalis Group plc.

From:
Competition and Markets Authority
Published
1 September 2003
Case type:
Mergers
Case state:
Closed
Market sector:
Pharmaceuticals
Outcome:
Mergers - phase 1 found not to qualify
Closed:
1 September 2003

Affected market: Pharmaceutical / biotechnology services

No. ME/1413/03

On the basis of the information available to it, the Office of Fair Trading has decided that the proposed acquisition of Vernalis Group plc by British Biotech plc does not qualify for investigation under the mergers provisions of the Enterprise Act 2002, because neither the UK turnover test nor the share of supply test in section 23 of the Act is met.  A relevant merger situation has, therefore, not been created.

Updates to this page

Published 1 September 2003

Related content